References
- Akgül, S., Derman, O., Alikaşifoğlu, M., & Aktaş, D. (2011). CYP1A1 polymorphism in adolescents with polycystic ovary syndrome. International Journal of Gynecology and Obstetrics, 112, 8–10. doi: 10.1016/j.ijgo.2010.07.032.
- Babu, K.A., Rao, K.L., Kanakavalli, M.K., Suryanarayana, V.V., Deenadayal, M., & Singh, L. (2004). CYP1A1, GSTM1 and GSTT1 genetic polymorphism is associated with susceptibility to polycystic ovaries in South Indian women. Reproductive Biomedicine Online, 9, 194–200. doi: 10.1016/S1472-6483(10)62129-3.
- Balen, A.H., Conway, G.S., Kaltsas, G., Techatraisak, K., Manning, P.J., West, C., & Jacobs, H.S. (1995). Polycystic ovary syndrome: The spectrum of the disorder in 1741 patients. Human Reproduction, 10, 2107–2111. doi: 10.1093/oxfordjournals.humrep.a136243.
- Esinler, I., Aktas, D., Otegen, U., Alikasifoglu, M., Yarali, H., & Tuncbileke, E. (2008). CYP1A1 gene polymorphism and polycystic ovary syndrome. Reproductive Biomedicine Online, 16, 356–360. doi: 10.1016/S1472-6483(10)60596-2.
- Goodarzi, M., & Azziz, R. (2006). Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. Best Practice & Research: Clinical Endocrinology & Metabolism, 20, 193–205. doi: 10.1016/j.beem.2006.02.005.
- Hakkak, R., Shaaf, S., Dunn, H., MacLeod, S., Fuchs, G., & Korourian, S. (2008). Effects of obesity and 7,12-dimethylbenz(a)anthracene (DMBA) treatment on hepatic CYP1A1 expression in ovariectomized obese Zucker rats. The FASEB Journal, 22, 886. Retrieved from: https://www.fasebj.org/doi/abs/10.1096/fasebj.22.1_supplement.886.1
- Hernandez, L.M., & Blazer, D.G. (2006). Genes, behaviour, and the social environment: moving beyond the nature/nurture debate. In L.M. Hernandez & D.G. Blazer (Eds.), Institute of Medicine (US) Committee on assessing interactions among social, behavioural, and genetic factors in health. Washington (DC): National Academies Press (US). Retrieved from: https://www.ncbi.nlm.nih.gov/books/NBK19934/
- Jain, M., Jain, S., Pandey, P., & Singh, K. (2015). Genetic polymorphism of CYP1A1 (T6235C) gene as a risk factor for polycystic ovary syndrome. Gynecology and Obstetrics, 5, 263. doi: 10.4172/2161-0932.1000263.
- Khlifi, R., Messaoud, O., Rebai, A., & Hamza-Chaffai, A. (2013). Polymorphisms in the human cytochrome P450 and arylamine N-acetyltransferase: Susceptibility to head and neck cancers. BioMed Research International, 2013, 1. doi: 10.1155/2013/582768.
- King, R., Rotter, J., & Motulsky, A. (2002). The genetic basis of common diseases (2nd ed.). New York: Oxford University Press.
- Lanca, V., Coelho, C., Pego, P., Moreira, H., Sardinha, L., Alcantara, P., … Bicho, M. (2002). Association of CYP1A1, ACE and p22phox polymorphisms with essential hypertension in postmenopausal women. American Journal of Hypertension, 15, 140A–141A. doi: 10.1016/S0895-7061(02)02655-9.
- Loft, A., Ziebe, S., Erb, K., Rasmussen, P.E., Agerholm, I., Hauge, B., … Lyby, K. (2005). Impact of follicular-fluid meiosis-activating sterol in an albumin-based formulation on the incidence of human pre-embryos with chromosome abnormalities. Fertility and Sterility, 84, 1269–1276. doi: 10.1016/j.fertnstert.2005.05.017.
- Neal, M.S., Zhu, J., Holloway, A.C., & Foster, W.G. (2007). Follicle growth is inhibited by benzo-[a]-pyrene, at concentrations representative of human exposure, in an isolated rat follicle culture assay. Human Reproduction, 22, 961–967. doi: 10.1093/humrep/del487.
- Shen, W., Li, T., Hu, Y., Liu, H., & Song, M. (2013). CYP1A1 gene polymorphisms and polycystic ovary syndrome: a meta-analysis and meta-regression. Genetic Testing and Molecular Biomarkers, 17, 727–735. doi: 10.1089/gtmb.2013.0209.
- Shen, W., Li, T., Hu, Y., Liu, H., & Song, M. (2014). Common polymorphisms in the CYP1A1 and CYP11A1 genes and polycystic ovary syndrome risk: A meta-analysis and meta-regression. Archives of Gynecology and Obstetrics, 289, 107–118. doi: 10.1007/s00404-013-2939-0.
- Son, D.S., Roby, K.F., Rozman, K., & Terranova, P.F. (2002). Oestradiol enhances and estriol inhibits the expression of CYP1A1 induced by 2,3,7,8 – tetrachlorodibenzo-p-dioxin in a mouse ovarian cancer cell line. Toxicology, 176, 229–243. doi: 10.1016/S0300-483X(02)00162-2.
- Sugawara, T., Nomura, E., Sagawa, T., Sakuragi, N., & Fujimoto, S. (2003). CYP1A1 polymorphism and risk of gynaecological malignancy in Japan. International Journal of Gynecological Cancer, 13, 785–790. Retrieved from: https://journals.lww.com/ijgc/Fulltext/2003/11000/CYP1A1_polymorphism_and_risk_of_gynecological.9.aspx
- The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Working Group. (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction, 19, 41–47. doi: 10.1093/humrep/deh098.
- Unsal, T., Konac, E., Yesilkaya, E., Yilmaz, A., Bideci, A., Ilke Onen, H., … Menevse, A. (2009). Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome. Journal of Assisted Reproduction and Genetics, 26, 205–216. doi: 10.1007/s10815-009-9308-8.
- Wang, B., Wang, J., Liu, J., Ni, F., Yan, J., Zhou, S., … Ma, X. (2009). Lack of an association between CYP1A1 gene Ile462Val polymorphism and polycystic ovary syndrome in Chinese. Endocrine, 36, 16–19. doi: 10.1007/s12020-009-9205-z.